Canopy Growth, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

+12.95%

+0.76%

0.00%

-0.89%

+0.28%

Canopy Growth Corporation CGC	1.88	+12.95%
Fresenius Medical Care AG & Co. KGaA Sponsored ADR FMS	23.82	+0.76%
Gamehaus Holdings Inc. Ordinary Shares GMHS	1.00	0.00%
Inventiva S.A IVA	4.44	-0.89%
Kenon Holdings Ltd. KEN	61.05	+0.28%

U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Tuesday.

Shares of Canopy Growth Corporation (NASDAQ:CGC) fell sharply in pre-market trading after the company disclosed a $200 million offering.

Canopy Growth shares dipped 10.5% to $1.61 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

ALT5 Sigma Corporation (NASDAQ:ALTS) declined 13.8% to $6.79 in pre-market trading after falling around 6% on Friday.
Inventiva S.A. (NASDAQ:IVA) fell 12.7% to $5.40 in pre-market trading.
Gamehaus Holdings Inc. (NASDAQ:GMHS) dipped 10.1% to $1.70 in pre-market trading. Gamehaus Holdings shares jumped 67% on Friday after the company announced a $5 million share repurchase program.
Tectonic Therapeutic, Inc. (NASDAQ:TECX) declined 10% to $22.99 in pre-market trading.
Valneva SE (NASDAQ:VALN) fell 6.2% to $8.30 in pre-market trading.
Fresenius Medical Care AG (NYSE:FMS) declined 6.2% to $24.12 in pre-market trading.
Kenon Holdings Ltd. (NYSE:KEN) dipped 5.1% to $44.59 in pre-market trading.
Mercurity Fintech Holding Inc. (NYSE:MFH) fell 3.8% to $6.72 in pre-market trading after gaining around 8% on Friday.
Upstream Bio, Inc. (NASDAQ:UPB) fell 3.1% to $16.61 in pre-market trading. Upstream Bio reported positive top-line results from the Phase 2 VIBRANT trial of Verekitug for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP).
NVIDIA Corporation (NASDAQ:NVDA) fell 2.2% to $170.28 in pre-market trading after declining more than 3% on Friday.

Now Read This:

Top 2 Consumer Stocks That May Collapse In Q3

Photo via Shutterstock

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.